Dabur India Limited, Sahibabad Unit
FDA import alert and refusal historyGhaziabad, IndiaFEI 3004326829
As of October 26, 2026, Dabur India Limited, Sahibabad Unit (Ghaziabad, India) is on the red list of FDA Import Alert 99-08 (Processed human and animal foods: pesticides) for triphala, published by FDA on September 16, 2009, and has 4 FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-08 · red list
- Last import refusal
- Herbals & botanicals (not teas), n.e.c. · UNAPPROVED
- Last warning letter
- None found
- Last inspection
- Classified VAI (Voluntary Action Indicated)
Every FDA record for Dabur India Limited, Sahibabad Unit
6 records, newest first. Each line links to the FDA page it came from.
2021
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.UNAPPROVEDEntry 799-5054752-0Source
2020
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.UNAPPROVEDEntry 799-8711568-8Source
2019
- Import refusalSource
Refused, 2 lines in one entry: Spices, flavors and salt not mentioned elsewhere, n.e.c.NO ENGLISHUSUAL NAMEEntry KM6-3527348-5Show 2 linesHide lines
- Refused, Spices, flavors and salt not mentioned elsewhere, n.e.c.NO ENGLISHUSUAL NAMEEntry KM6-3527348-5Source
- Refused, Spices, flavors and salt not mentioned elsewhere, n.e.c.NO ENGLISHUSUAL NAMEEntry KM6-3527348-5Source
2016
- InspectionInspection classified VAI (Voluntary Action Indicated)Food Composition, Standards, Labeling and EconSource
2009
- Import alert listingListed on Import Alert 99-08red listTriphalaSource
Refusal charges, in plain English
- NO ENGLISH2 refused lines
Required label information not in English
Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.
- UNAPPROVED2 refused lines
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
- USUAL NAME2 refused lines
Common or usual name missing
The label appeared not to show the common or usual name of the food.
Questions about Dabur India Limited, Sahibabad Unit
- Is Dabur India Limited, Sahibabad Unit on an FDA import alert?
- Yes. As of October 26, 2026, Dabur India Limited, Sahibabad Unit is on the red list of FDA Import Alert 99-08, “Processed human and animal foods: pesticides”, for triphala; FDA published the listing on September 16, 2009.
- Has FDA refused shipments from Dabur India Limited, Sahibabad Unit?
- Yes. FDA refused 4 shipment lines from Dabur India Limited, Sahibabad Unit between September 4, 2019 and October 15, 2021. The most recent, on October 15, 2021, was herbals & botanicals (not teas), n.e.c., charged as UNAPPROVED (unapproved new drug).
- Why did FDA refuse Dabur India Limited, Sahibabad Unit's shipments?
- The most frequent charges are NO ENGLISH (required label information not in english, 2 lines) and UNAPPROVED (unapproved new drug, 2 lines).
- When was Dabur India Limited, Sahibabad Unit last inspected by FDA?
- FDA's most recent inspection of Dabur India Limited, Sahibabad Unit with a final classification is dated July 15, 2016 and was classified VAI (Voluntary Action Indicated).
- What is Dabur India Limited, Sahibabad Unit's FEI number?
- Dabur India Limited, Sahibabad Unit's FDA Establishment Identifier (FEI) is 3004326829.
- Can shipments from Dabur India Limited, Sahibabad Unit still enter the U.S.?
- Shipments of triphala from Dabur India Limited, Sahibabad Unit can be detained without physical examination under Import Alert 99-08; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Dabur India Limited, Sahibabad Unit?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.